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1. Introduction 
Entamoeba histolytica is a protozoan parasite that causes amebic dysentery and liver abscess. 
The disease is common in tropical regions of the world where hygiene and sanitation is 
often approximate. The epidemiology of E. histolytica has been studied around the world. 
However, there is a dearth of comprehensive literature on the epidemiology of this 
pathogen as well as its pathogenicity in the tropical and underdeveloped regions of the 
world where the disease is actually more common. Epidemiological figures in many 
endemic tropical countries are often overestimated because of inaccurate identification. 
Accurate data on the prevalence of the pathogenic strain(s) of E. histolytica in those regions 
will allow for the effective cure of patients with anti-amoebic drugs thus preventing the 
development of resistant types and reducing management costs.  
With the advents of HIV and AIDS, several organisms have been identified as potential 
opportunistic pathogens. However, it is not clear whether amoebiasis is an opportunistic 
infection or not. Up to date, very little data has been published on the occurrence of E. 
histolytica in relation to HIV and AIDS. In developed countries amebiasis tends to be more 
common in older patients and occurs mostly among men who have sex with men or in 
institutions. However, in tropical regions, the epidemiology of amoebiasis is completely 
different and is more common among the general population and particularly among 
patients attending health care centers with diarrhea. Therefore, it is important to understand 
the epidemiology of this pathogen in tropical areas where it is responsible for most 
morbidity and mortality.  
The recent reclassification of E. histolytica into different species now including the 
pathogenic Entamoeba histolytica and the non pathogenic Entamoeba dispar and Entamoeba 
moshkovskii  has further added to the complexity of the epidemiology of amoebiasis since 
these three species cannot be differentiated by microscopy that is the most commonly used 
diagnostic method particularly in tropical countries where resources are limited, but can 
only be differentiated by the use of molecular methods such as the polymerase chain 
reaction based methodologies. Recent development of simpler but more sensitive methods 
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such as the Loop-Mediated Isothermal Amplification (LAMP) should improve the 
understanding of the epidemiology of this disease.  
Over the past few years we have studied the epidemiology of E. histolytica in African 
countries (Cameroon, Zimbabwe, and South Africa). In the present chapter, we review these 
and other studies conducted in the African continent as well as other tropical regions in the 
light of new and more specific and sensitive molecular methods. The pathogenesis 
mechanism of amoebiasis is still not clear and recently differences in population levels of E. 
histolytica strains isolated from asymptomatic and symptomatic individuals have been 
shown to exist. One of the factors believed to be the determinant of the various clinical 
presentations of the disease is the organism’s virulence. The different methodologies used 
for the detection and epidemiology of amoebiasis will be reviewed as well as the role of E. 
histolytica in HIV disease. Recent advances on the pathogenesis and control of amoebiasis 
will also be reviewed.  
Amoebiasis caused by the protozoan parasite E. histolytica was first recognized as a deadly 
disease by Hippocrates who described a patient with fever and dysentery (460 to 377 B.C.). 
With the application of a number of new molecular biology-based techniques, tremendous 
advances have been made in our knowledge of the diagnosis, natural history, and 
epidemiology of amoebiasis. Amoebiasis remains an important health problem in tropical 
countries where sanitation infrastructure and health are often inadequate (Ximénez et al., 
2009). Clinical features of amoebiasis range from asymptomatic colonization to amoebic 
colitis (dysentery or diarrhea) and invasive extraintestinal amoebiasis, which is manifested 
most commonly in the form of liver abscesses (Fotedar et al., 2007). Current WHO estimates 
of 40-50 million cases of amoebic colitis and amoebic liver abscess (ALA) and up to 100,000 
deaths annually, place amoebiasis second only to malaria in mortality (Stanley 2003; Ravdin 
2005; WHO/PAHO/UNESCO 1997). Global statistics on the prevalence of E. histolytica 
infection indicates that 90% of individuals remain asymptomatic while the other 10% 
develop clinically overt disease (Jackson et al, 1985; Haque et al., 1999). Although all the 
deaths could be due to invasive E. histolytica infections, the value for the prevalence of E. 
histolytica is an overestimate since it dates from before the separation of the pathogen E. 
histolytica from the non-pathogen E. dispar (Diamond & Clark, 1993). Recently however, 
Entamoeba moshkovskii, a morphologically identical species, has been detected in individuals 
inhabiting endemic areas of amoebiasis (Ali et al., 2003, Fotedar et al., 2008, Khairnar et al., 
2007, Parija & Khairnar, 2005) and could be contributing to the prevalence figures. Thus, the 
reclassification of E. histolytica into the three morphologically identical yet genetically 
different species has further added to the complexity of the epidemiology of amoebiasis 
since they cannot be differentiated by microscopy that is the most commonly used 
diagnostic method particularly in tropical countries where resources are limited. 
Furthermore, the worldwide prevalence of these species has not been specifically estimated. 
Thus, obtaining accurate species prevalence data remains a priority as there are gaps in our 
knowledge for many geographic regions of the tropics. 
Although only a minority of E. histolytica infections - one in every four asymptomatic 
intestinally infected individuals - progress to development of clinical symptoms (Gathiram 
and Jackson, 1987; Blessmann et al., 2003; Haque et al., 2006), the exact basis for this 
difference remains mostly unsolved. This might be partly due to the differences in the 
pathogenic potential of the infecting strains (Burch et al., 1991) and/or the parasite genotype 
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(Ali et al., 2007) or due to the variability of the host immune response against amoebic 
invasion (Mortimer and Chadee, 2010). 
The disease mechanism and the exact prevalence and incidence of infection caused by E. 
histolytica are still unknown. The epidemiological data available for endemic countries 
however, albeit sporadic, is based mostly on the microscopic identification of the E. 
histolytica/E. dispar/E. moshkovskii complex, often inaccurately reported as “E. histolytica”. To 
date many highly sensitive and specific techniques such as enzyme-linked immuno-sorbent 
assays (ELISA) and polymerase chain reaction (PCR) have been developed for the accurate 
identification and detection of E. histolytica in various clinical samples (Ackers, 2002). It is 
anticipated that these molecular tools will allow us to reconstruct a more reliable picture of 
the true epidemiology of the disease mainly in endemic regions of the world and to better 
our understanding of the role of the parasite and/or host factors that determine the disease 
outcome.      
2. Biology of Entamoeba histolytica  
Entamoeba histolytica trophozoites (Figure 1) live and multiply indefinitely within the 
mucosa of the large intestine feeding normally on starches and mucous secretions and 
interacting metabolically with the host's gut bacteria. However, such trophozoites 
commonly initiate tissue invasion when they hydrolyze mucosal cells and absorb the 
predigested products in order to meet their dietary provisions. Filopodia (tiny cytoplasmic 
extensions) that form from the surface of their trophozoites are believed to play a role in the 
pathogenicity of certain strains. Examples of functions related to pathogenesis include: 
endocytosis and/or pinocytosis, exocytosis, tissue penetration, cytotoxic substances release 
or contact cytolysis of host cells. Other host factors that may also influence the invasiveness 
of E. histolytica are the oxidation-reduction potential and gut contents pH both of which are 
largely influenced by the overall nutritional state of the host.  
Once the parasites invade the intestinal wall, they reach the submucosa and the underlying 
blood vessels. From there, trophozoites travel in the blood to sites such as the liver, lungs or 
skin. These parasite forms are now considered to be dead-end course since they cannot leave 
the host and cause infection in others. Encystation occurs in the intestinal lumen, and cyst 
formation is complete when four nuclei are present. These infective cysts are passed into the 
environment in human feces and are resistant to a variety of physical conditions. On 
occasions, trophozoites may exit in the stool, but they cannot survive outside the human 
host. The signals leading to encystations or excystation are poorly understood, but findings 
in the reptilian parasite Entamoeba invadens suggest that ligation of a surface galactose-
binding lectin on the surface of the parasite might be the one trigger for encystations 
(Stanley, 2003; Eichinger, 2001). Also, several previous proteomic and transcriptomic studies 
have shown that a few dozens of Rab genes/proteins are involved in important biological 
processes, such as stress response, virulence, and pathogenesis, and stage conversion 
(Picazarri et al., 2008; Chatterjee et al., 2009; Novick and Zerial, 1997; Stenmark, 2009; 
Nozaki and Nakada-Tsukui, 2006). EhRab11A was reported to be recruited to the cell 
surface by iron or serum starvation, and was suggested to be involved in encystation 
(McGugan and Temesvari, 2003). In contrast, EhRab11B is involved in cysteine protease 
secretion, and its overexpression enhanced the secretion of cysteine protease (Mitra et al., 
2007; Nozaki and Nakada-Tsukuia, 2006).  
www.intechopen.com
 
Current Topics in Tropical Medicine 
 
204 
  
Fig. 1. Entamoeba histolytica trophozoites observed under the microscope stain with 
methylene blue (Observe that the cells did not accept the stain since they were still alive at 
the time the picture was taken) (Photos by Samie A) 
The life cycle of E. histolytica is simple and consists of an infective cyst stage (10 to 15 μm 
in diameter) and a multiplying trophozoite stage (10 to 60 μm in diameter). Like other 
protozoa, E. histolytica appears incapable of de novo purine synthesis. Biochemical 
analysis has indicated that glutathione is not present. For this reason, E. histolytica is 
different from higher eukaryotes. It also uses pyrophosphate instead of ATP (McLaughlin 
and Aley, 1985). Mature cysts in the large intestine leave the host in large numbers and 
remain viable and infective in a moist, cool environment for at least 12 days. In water, 
cysts can live for up to 30 days. Nonetheless, they are rapidly killed by desiccation, and 
temperatures below 5°C and above 40°C. Mature cysts are also resistant to chlorine levels 
normally used to disinfect water. When swallowed, cysts pass through the stomach 
unharmed. In the small intestine, where conditions are alkaline and as a result of nuclear 
division, eight motile trophozoites are produced. These motile trophozoites then settle in 
the large intestine lumen, where they divide by binary fission and feed on host cells, 
bacteria and food particle (Figure 2). This is the first chance of the parasite making contact 
with the mucosa. 
The organisms' biochemistry and metabolism have been reviewed by McLaughlin and Aley 
(1985). It has many hydrolytic enzymes, including phosphatases, glycosidases, 
proteinases, and an RNAse. Major metabolic end products are carbon dioxide, ethanol 
and acetate. E. histolytica is more of a metabolic opportunist which is able to exploit 
oxygen when it is present in the environment. Glucose is metabolized via the Embden-
Meyerhof pathway exclusively, and fructose phosphate is phosphorylated, prior to lysis, 
by enzymatic reactions unique to Entamoeba spp. Pyruvate is converted mostly to ethanol, 
even in the presence of oxygen, via coenzyme-A, and pyruvate oxidase. Terminal electron 
transfers are accomplished with ferredoxinlike iron-sulphur proteins, a trait that may 
contribute to the efficacy of metronidazole in treatment. Similar metabolic traits in 
Trichomonas vaginalis and Giardia lamblia also are metronidazole targets. Mitogen 
Activated Protein Kinases (MAPK) – a group of proline directed serine/threonine kinases 
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(Bardwell, 2006) - regulate a number of different cellular processes such as proliferation, 
and response to a variety of environmental stresses like osmotic stress, heat shock and 
hypoxia (Junttila, 2008). The existence of MAPK homologues has been documented in 
certain parasitic protozoa. For instance ERK1 and ERK2 homologues of Giardia lamblia 
have been shown to play a critical role in trophozoite differentiation into cysts (Ellis et al., 
2003), Pfmap2, a MAPK homologue in Plasmodium falciparum is essential for the 
completion of the asexual phase of the parasite lifecycle (Dorin-Semblat et al., 2006) and 
Leishmania major MAPK homologues exhibit an increased phosphotransferase activity in 
response to pH and temperature shift (Morales et al., 2007). On the other hand, E. 
histolytica has been shown to possess a single homologue of a typical MAPK gene 
(EhMAPK). Activation of EhMAPK in E. histolytica has been found to be associated with 
stress survival such as heat shock and oxidative stress response (Ghosh et al, 2010). 
 
 
 
Fig. 2. Life cycle of E. histolytica/E. dispar. a) Mature cyst stained with 4% Lugol solution 
(100× magnification). b) Mature cyst without staining (100×). c) Trophozoite observed 
with differential interference contrast (DIC) (100×). d) Trophozoites of E. histolytica species 
with phagocyted erythrocytes (DIC 40×). Obtained with permission from Ximenez et al 
(2011). 
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3. Epidemiology of amoebiasis and its occurrence in the era of HIV and AIDS 
The epidemiology of amoebiasis around the world is complicated by the existence of three 
different forms that are morphological identical but genetically distinct and include E. 
histolytica which is a known pathogen, E. dispar and E. moshkovskii which are non pathogens 
(Ali et al., 2008). This is particularly relevant to the African continent as well as many other 
developing countries in the world, including Latin American and Asian countries, where 
there is lack of specific diagnostic tools. According to some studies conducted in some 
African countries (Alonzo et al., 1993; Molback et al., 1994; Njoya et al., 1999; Roche et al., 
1999) from 6% to 75% of the population carry the parasite. These studies were conducted 
using microscopic examination giving a general idea on the distribution of the disease in the 
population. Such results require confirmation by techniques that clearly differentiate E. 
histolytica from E. dispar, which is not pathogenic. Countries in Central and Latin America 
where the parasite displays endemic behavior include Mexico, Brazil, and Ecuador. In 
Mexico for example, the incidence rate of intestinal amoebiasis from 1995 to 2000 was 
reported to be between 1000 and 5000 cases/100,000 inhabitants annually.  Incidence values 
from 2002 to 2006 were 1128.8 to 615.85/100,000 inhabitants per year. As in other 
developing countries, those under 15 years of age were the most frequently affected group, 
with a notable increase in children aged 5–9 (Ximenez, 2009).  In Aracaju, Brazil, Lawson et 
al (2004) demonstrated E. histolytica in 1% of cases whereas E. dispar was found in 13% of the 
cases. Whilst in Pernambuco state, northeastern Brazil E. dispar was found in 74.19% of 
culture positive samples using the PCR method, no E. histolytica was reported (Pinheiro et 
al., 2004).  In a remote area of Ecuador, Gatti et al (2002) using isoenzyme analysis reported 
an 18.9% infection rate with E. histolytica while 70.3% were infected with E. dispar. In the 
Indian subcontinent, the prevalence of intestinal amoebiasis among hospitalized patients 
was found to be around 11.7% using microscopy. However, using molecular biology tools 
such as PCR, E. histolytica was shown to be in 3.5% of those infected (Khairnar et al., 2007).  
In another endemic country such as Bangladesh and using ELISA antigen detection kits, E. 
histolytica prevalence was found to be 4.2% among children living in the urban slums of 
Dhaka (Haque et al. 2006).  Many studies have been conducted in different parts of the 
world, (Ghosh et al., 2000) but the region most concerned by this problem (Africa) remains 
unexplored. Thus, the epidemiology of amoebiasis still remains very uncertain particularly 
in this part of the world. 
Following the HIV/AIDS pandemic, numerous studies demonstrated that intestinal 
parasites such as Cryptosporidium sp, Microsporidia sp, Isospora belli, and Cyclospora 
cayetenensis were frequently associated with episodes of severe and often fatal diarrhea in 
both industrialized and poor countries. There have been controversies around the impact of 
HIV on the occurrence of amebiasis. However, recent data have shown an increase in the 
occurrence of E. histolytica among HIV patients in countries such as Japan, Mexico, Taiwan, 
and South Africa (Moran et al., 2005; Hung et al., 2008; Samie et al., 2009; Watanabe et al., 
2011). With the hall mark of HIV infection being the depletion of CD4+ T cells count (below 
200 cells/µl) and the progressive decline of the mucosal immunologic defense mechanisms, 
HIV/AIDS patients become prone to life-threatening gastrointestinal manifestations such as 
diarrhea (Stark et al., 2009). Table 1 provides a summary of the prevalence studies reporting 
E. histolytica and/or E. histolytica / E. dispar infections in HIV positive individuals in different 
countries. The association of E. histolytica infections with HIV positive individuals in some 
studies is not clear-cut. In a Mexican study no clear association between E. histolytica and 
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HIV has been noted. In this study, the prevalence of E. histolytica in HIV/AIDS patients was 
25.3% compared to 18.4% in a control HIV-group (Moran et al., 2005). Other studies in South 
American countries have shown no obvious association. However, a significant association 
between high levels of serum anti-E. histolytica antibodies and the presence of E. histolytica in 
the stool has been noted in studies from both Vietnam (Blessman et al., 2006) and Africa 
(Stauffer et al., 2006). In a South African study in the Vhembe district in the northern part of 
the country, a positive association between E. histolytica infection and HIV-positive 
individuals has been indicated. Among the HIV-positive individuals, those with CD4+ 
count less than 200 cells/µl, were relatively more likely to be seropositive for E. histolytica 
(Samie et al., 2010). In a Chinese study, a higher seroprevalence of E. histolytica infections was 
also found in HIV-infected patients (Chen et al, 2007). Furthermore, two studies conducted in 
Taiwan revealed a positive association as well (Hung et al., 2005; Tsai et al., 2006).          
 
Country Prevalence of Entamoeba species Reference 
Cuba 1.5% (E. histolytica/dispar) Escobedo, A. A. 1999 
Bogota, Colombia 13% (E. histolytica) Florez et al., 2003 
San Pedro Sula, 
Honduras 
5.8%(E. histolytica) Lindo et al., 1998 
Venezuela (Zulia state) 10.8%(E. histolytica) Rivero et al., 2009 
Brazil  3.3% and 1% (E. histolytica/ dispar 
before and after HAART) 
Bachur et al., 2008 
Mexico 25.3% in HIV+ and 18.5% in  HIV- 
contacts (E. histolytica) 
Moran et al., 2005 
Tajikistan 25.9% (E. histolytica/dispar non 
HIV) 
Matthys et al., 2011 
Northern India 7.7% (E. histolytica) Prasad et al., 2000 
Taiwan  5.8% (E. histolytica in HIV 
patients) 
Hung et al., 2008 
Bangladesh 2.1% vs. 1.4% in diarrhea and 
control (E. histolytica) 
Haque et al., 2009 
India (Kolkata) 3.6% (E. histolytica) Mukherjee et al., 2010 
Sydney, Australia 3.2% (E. histolytica/E. dispar) Stark et al., 2007 
Mazandaran province, 
Iran 
1.6% (E. histolytica) Daryani et al., 2009 
Uganda 1.4% (E. histolytica) Brink et al., 2002 
Ethiopia 10.3% (E. histolytica) Hailemariam et al., 2004 
Dakar, Senegal 5.1% (E. histolytica) Gassama et al., 2001 
South Africa 12.4% (E. histolytica) Samie et al., 2006 
Table 1. Global prevalence of E. histolytica in HIV-infected and non-infected persons. 
Over the past decade, there has been an increasingly reported risk of amebiasis in East 
Asian countries like Japan, Taiwan and South Korea particularly among men who have sex 
with men (MSM) probably due to oral-anal sexual contact (Hung et al., 2008; Watanabe et 
al., 2011). In Japan, E. histolytica often occur in institutions of mentally retarded individuals 
where outbreacks of amebiasis have been described with the prevalence rate and positive 
serology rate as high as 38.2% and 67.1%, respectively (Nishise et al., 2010) and has been 
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occurring more often in HIV positive patients (Watanabe et al., 2011). In addition to 
HIV/AIDS, the increasing use of organ transplants and other immunosuppressed 
conditions such as neutropenia have been considered important risk factor for invasive 
amoebiasis in many countries. In Colombia for example, a study of organ transplant patients 
revealed that about 24.7% had detectable antiamoebic antibodies (Reyes et al., 2006) whereas 
in another study 14.3% neutropenic patients were found to have antiamoebic antibodies 
(Cardona et al., 2004).  
Certain risk behaviors, such as homosexual relations and practicing oro-anal sex, can 
exacerbate the possibility of acquiring E. histolytica infections as well as other intestinal 
parasites such as Cryptosporidium spp., where the symptomatic pictures are more severe 
than those of immunocompetent individuals (Tatiana et al., 2008; Hung 2008). A recent 
study in Vietnam had indicated that socio-economic and personal hygiene factors 
determined infection with E. histolytica, rather than exposure to human and animal excreta 
in agricultural activities (Pham duc et al., 2011). In a study in Bangladesh, it was shown that 
wet environment is not the only factor that affects the detection curve of E. histolytica, but 
anti-Carbohydrate Recognition Domain IgA level in the gut is another determining factor 
for its occurrence in a closed population (Haque et al., 2006). Although, numerous 
seroprevalence studies suggest that HIV/AIDS individuals are at a higher risk of E. 
histolytica infections and are therefore more likely to develop symptomatic infections or 
severe forms of the disease, modest data exist to support these findings and further research 
is needed to confirm this hypothesis.    
4. Diagnosis of amoebiasis 
Amoebiasis diagnosis rests on the demonstration of E. histolytica trophozoites or cysts in 
stool or colonic mucosa of patients. For many years a direct smear examined either as a wet 
mount or fixed and stained was done by microscopic examination of stool. Repeated stool 
sample examinations (at least three) may be needed. The presence of haematophagous 
amoebic trophozoites in a stool sample has always suggested E. histolytica infections 
(Gonzalez-Ruiz, A. et al 1994). Nonetheless, the specificity of this finding was further 
reduced when it was demonstrated that in some patients E. dispar also contains RBCs 
(Fotedar et al., 2007). Also, in view of the high frequency of E. dispar in many areas, 
dysentery due to entities such as shigellosis and campylobacter will probably be 
misdiagnosed as amoebic colitis if microscopy is the sole diagnostic criteria (Stanley 2003). 
However, in the absence of haematophagous trophozoites, the sensitivity of microscopy is 
limited by its ability to distinguish between samples infected with E. histolytica and the 
morphologically identical E. dispar and E. moshkovskii. Confusion between E. histolytica, other 
non-pathogenic amoeba and white blood cells such as macrophages and 
polymorphonuclear cells in feces frequently result in the overdiagnosis of amoebiasis. 
Delays in the processing of stool samples affect the sensitivity of light microscopy, which 
under the best circumstances is only 60% of that of the stool culture method followed by 
isoenzyme analysis (Krogstad et al., 1978).  
Stool culture technique followed by isoenzyme analysis has been considered as the "gold 
standard" for many years. This method has been used to distinguish between E. histolytica 
and E. dispar. For more details on the culture technique the reader is advised to consult 
reference (Clark and Diamond, 2002). Culture of E. histolytica can be performed from fecal 
specimens, rectal biopsy specimens, or liver abscess aspirates. However, the process usually 
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takes between 1-4 weeks to perform and requires sophisticated laboratory equipment 
making it not feasible as a routine procedure especially in the developing world where E. 
histolytica is rampant. The rate of success of E. histolytica culture in reference laboratories has 
been reported to be between 50 and 70%. Moreover, isoenzyme (zymodeme) analysis is 
labor intensive, costly and often produces false-negative results for many microscopy 
positive stool specimens (Strachan et al., 1988). 
Serological methods may be useful diagnostically to detect infections with E. histolytica in 
developed countries where infections are not as common as in endemic developing nations 
(Ohnishi et al., 1997). In developing countries individuals are constantly exposed to E. 
histolytica making serological tests unable to definitively distinguish past from current 
infections (Caballero et al., 1994). Amoebic serology is highly sensitive and specific for the 
diagnosis of ALA (Zengzhu et al., 1999). Conversely, a study of asymptomatic individuals 
living in an E. histolytica endemic area of Vietnam revealed that about 83% of those infected 
had detectable anti-amoebic antibodies (Blessmann et al., 2002). Several assays for the 
detection of antibodies to E. histolytica infections have been developed (Table 2). These 
include:  indirect hemagglutination (IHA), latex agglutination, immunoelectrophoresis, 
counterimmunoelectrophoresis (CIE), the amebic gel diffusion test, immunodiffusion, 
complement fixation, indirect immunofluorescence assay (IFA), and enzyme-linked 
immunosorbent assay (ELISA). With the exception of ELISA, all the other tests have been 
either costly to perform (Complement fixation), less sensitive and nonspecific (IHA and 
Latex agglutination test), time consuming (immunodiffusion) or requires skills in culture 
and antigen preparation (IFA) (Fotedar et al., 2007).  
 
Serological Assay Sensitivity (%) Specificity (%) Reference(s) 
IHA 100a, 99  90.9-100a , 99.8 Pillai et al., 1999; 
Hira et al., 2001 
Novagnost Entamoeba IgG    >95 >95 Manufacturer’s 
recommendation 
I.H.A. Amoebiasis 93 97.5 Robert et al., 1990 
Amebiasis Serology microplate 
ELISA 
95 97 Manufacturer’s 
recommendation 
RIDASCREEN Entamoeba (IgG 
detection) 
100, 97.7-100 (100) 95.6, 97.4 (100) Manufacturer’s 
recommendation; 
Knappik et al., 2005 
Table 2. List of some of the commercially available antibody assays used for the diagnosis of 
amoebiasis. 
ELISA is a reliable, easy to perform and rapid method for the diagnosis of E. histolytica 
infections especially in developing countries. It has been used widely for the study of the 
epidemiology and diagnosis of symptomatic amoebiasis (intestinal and/or extraintestinal).  
An ELISA to detect antibodies to E. histolytica has been shown to be 97.9% sensitive and 
94.8% specific for detection of E. histolytica antibodies in ALA patients in a non endemic 
country (Hira et al., 2001). Unlike IgG, immunoglobulin M (IgM) is short lived and does not 
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remain in the serum for longer periods making it a very useful marker for the detection of 
present or current E. histolytica infections. An ELISA for the detection of serum IgM 
antibodies to the amoebic Gal or GalNAc-inhibitable adherence lectin has been reported. In 
this study, conducted in Egypt, anti-lectin IgM antibodies in the serum were detected in 45% 
of patients who had been suffering from acute colitis for <1 week (Abd-Alla et al., 1998). 
Since there is no cross-reaction with other non-E. histolytica parasites (Goncalves et al., 2004), 
the use of ELISA thus seems to be an excellent choice for the routine laboratory diagnosis as 
well as the surveillance and control of amoebiasis in the developing world.   
The newer methods available to distinguish between E. dispar and E. histolytica have thrown 
into question the commonly accepted figure of 500 million infections worldwide suggesting 
that the actual number may be closer to 50 million. PCR and monoclonal antibody 
techniques are now available to distinguish between these three species in fresh and 
preserved stool samples, including those with mixed infections. Several investigators have 
developed ELISAs that detect antigens in fresh stool samples with sensitivity closer to that 
of stool culture methods and PCR. These ELISAs are usually easy and rapid to perform. 
Copro-antigen based ELISA kits  specific for E. histolytica exploit monoclonal antibodies 
against the Gal/GalNAc-specific lectin of E. histolytica (E. histolytica II; TechLab, Blacksburg, 
VA) or against serine-rich antigen of E. histolytica (Optimum S kit; Merlin Diagnostika, 
Bornheim-Hersel, Germany). Other ELISA kits include the Entamoeba CELISA PATH kit 
(Cellabs, Brookvale, Australia) and the ProSpecT EIA (Remel Inc.; previously manufactured 
by Alexon-Trend, Inc., Sunnyvale, CA) (Fotedar et al., 2007). The early nineties of the 20th 
century have witnessed the introduction by TechLab of an ELISA kit for the specific 
detection of E. histolytica in feces. This antigen detection test captures and detects the 
parasite's Gal/GalNAc lectin in stool samples. It can also be used for the detection of the 
lectin antigen in the serum and liver abscesses in patients with invasive intestinal 
amoebiasis and ALA (Haque et al., 2000). However, the diagnosis of ALA normally relies on 
the identification of liver lesions and positive anti-E. histolytica serology. Yet neither 
provides conclusive results for ALA. The Gal/GalNAc lectin is conserved and highly 
immunogenic, and because of the epitopic differences in the lectins of E. histolytica and E. 
dispar, the test enables specific identification E. histolytica (Haque et al., 1993; Mirelman 
1997). Because of some disadvantages observed with the TechLab ELISA kit, a newer more 
sensitive and specific version, TechLab E. histolytica II kit, was produced. This second –
generation E. histolytica II kit has demonstrated good sensitivities and specificities when 
compared to real-time PCR (71 to 79% and 96 to 100%, respectively) (Roy et al., 2005; Visser 
et al., 2006). Other studies however, have reported a lesser sensitivity (14.3%) and specificity 
(98.4%) in comparison to stool culture and isoenzyme analysis (Gatti et al., 2002). Cross 
reactivity is another concern with the use of the assay, since it seems that E. dispar positive 
samples by means of PCR may sometimes give false-positive outcomes (Furrows et al., 
2004). Accordingly, accurate detection of E. histolytica, E. dispar and E. moshkovskii could be 
helpful for diagnostic and epidemiological studies in places where it is impractical and 
expensive to use molecular assays and where amoebiasis is most prevalent, such as in the 
developing countries. An antigen detection kit for the specific identification of E. dispar and 
E. moshkovskii is yet to be developed.  
Several PCR-based techniques that amplify and detect E. histolytica DNA are currently used 
for the clinical and epidemiological studies in non-endemic rich countries (Acuna-Soto et al., 
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1993; Katzwinkel-Wladarsch  et al., 1994; Calderaro et al., 2006; Hamzah et al., 2006). The 
sensitivity and specificity of PCR-based methods for the diagnosis of E. histolytica infection 
approach those of stool culture followed by isoenzyme analysis. PCR methods can be used 
to detect E. histolytica in stool, tissues and liver lesion aspirates. Of all the different gene 
targets used to identify E. histolytica, the small-subunit rRNA gene (18SrDNA) is believed to 
be more sensitive than the best antigen detection method used and performs equally well 
compared to stool culture (Mirelman et al., 1997). 
Several groups have developed a variety of excellent conventional PCR assays, targeting 
different genes, for the direct detection and differentiation of E. histolytica, E. dispar, and E. 
moshkovskii DNA in clinical specimens such as stool and liver abscess samples (Tanyuksel 
and Petri Jr., 2003; Paul et al., 2007). Of all the targeted genes, assays amplifying the 
18SrDNA genes are the ones in wide use as they are present in multiple copies on 
extrachromosomal plasmids thus making them easily detectable than single copy genes 
(Battacharya et al., 1989).  Other gene targets used in PCR to study the epidemiology of E. 
histolytica include: the serine-rich E. histolytica protein (SREPH) gene (Stanley et al., 1990), 
cysteine proteinases gene and actin genes (Freitas et al., 2004). The SREHP is also used to 
study the genotypes of E. histolytica in human populations. However, it is now being 
replaced by the use of PCR amplification of tRNA gene-linked short tandem repeats which 
in addition to providing details of the epidemiology of E. histolytica, it also provides a tool to 
predict the outcome of the infection (Ali et al., 2005).      
A nested multiplex PCR was developed by many groups. This method has the added 
advantage of increasing the sensitivity and specificity of the test whilst simultaneously 
detecting and differentiating E. histolytica and E. dispar from DNA extracted from 
microscopy-positive stool specimens (Evangelopoulos et al., 2000; Hung et al., 2005; Nunez 
et al., 2001). A nested PCR method for the identification of E. moshkovskii in fecal samples 
was developed as a nested 18S rDNA PCR followed by restriction endonuclease digestion 
(Ali et al., 2003). The method exhibited a high sensitivity and specificity (100%). 
Real time PCR is another type of PCR which is more sensitive than the conventional PCR. It 
is faster than the conventional PCR and characterized by the elimination of gel analysis and 
other post-PCR analysis, thus reducing the risk of contamination and cost (Klein 2002). 
However, its application in developing countries is limited to research only. Real-time PCR 
allows specific detection of the PCR product by binding to one or two fluorescence-labeled 
probes during PCR, thereby enabling continuous monitoring of the PCR product formation 
throughout the reaction. Furthermore, real-time PCR is a quantitative method and allows 
the determination of the number of parasites in various samples (Fotedar et al., 2007). 
Despite being used for the successful identification of E. histolytica, E. dispar and E. 
moshkovskii, the various PCR methods use is still confined to research institutes in the 
developing world where amoebiasis is endemic. PCR-based methods application in routine 
clinical diagnostic laboratories in low income societies is hindered by difficulties such as 
cost, and time to perform the test.  
A new platform for the detection of pathogens has been developed known as loop-mediated 
isothermal amplification (LAMP) and was developed in 2000 by Notomi and colleagues. 
This method uses a set of two specifically designed inner primers and two outer primers 
that recognize six distinct regions of the targeted DNA. The reaction is performed under 
isothermal conditions and simple incubators, such as a water bath or heat block, are 
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adequate for the specific amplification of the desired genetic material. Considering these 
advantages, the LAMP assay could be a useful and valuable diagnostic tool particularly in 
developing countries where most of the infections are common as well as in hospital 
laboratories. Recently this method was developed specifically for the detection of E. 
histolytica (Liang et al., 2009). The efficiency of the developed method was compared to that 
of existing PCR methodology and was similar in terms of sensitivity and specificity. This 
method needs further evaluations to be used in local conditions in Africa in order to 
improve the understanding of amebiasis in the continent as well as elsewhere.  
5. Pathogenicity of amoebiasis 
E. histolytica causes intestinal and extraintestinal amoebiasis based on the site of infection. 
Though most infections do not harm the host (asymptomatic infections), establishment in 
the colonic mucosa via the Galactose/N-acetyl Galactosamine inhibitable lectin (Gal-lectin) 
is a pre-requisite for the disease (Chadee et al., 1987). Pathogenic forms of the parasite are 
known to secrete enzymes that facilitate their invasion into the mucosa and sub-mucosa 
causing deep-flask shaped ulcers (Figure 3), and in some cases entering the circulation and 
reaching internal organs like the liver, lungs,  skin, etc. The disease in the colon is the most 
common with acute diarrhoea and dysentery accounting for 90% of the clinical amoebiasis 
cases (Espinosa-Cantellano and Martínez-Palomo, 2000) and only 1% involve the liver 
(Haque et al., 2003) (Figure 4).  
5.1 Asymptomatic colonization 
Asymptomatic infections are characterized by the parasite living in perfect harmony within 
the host. E. histolytica trophozoites have developed elusive tactics to prevent them from 
being purged from the host.. By modulating signals by intestinal epithelial cells (IEC), 
trophozoites direct anti-inflammatory host responses leading to a 
tolerogenic/hyporesponsive immune state favourable to their survival (Kammanadiminti 
and Chadee, 2006). Furthermore, products secreted by non-pathogenic E. histolytica strains 
normally disrupt and suppress NFκB signaling and as a result diminish pro-inflammatory 
responses normally detrimental to the parasite (Artis, 2008). Interleukin 10 (IL-10), an anti-
inflammatory cytokine, has been shown to play a significant role in maintaining this 
hyporesponsive state. On the other hand, a deficiency of IL-10 more often than not 
predisposes the host to develop the clinical amoebiasis (Hamano et al., 2006) 
5.2 Intestinal amoebiasis 
After an incubation period of 1-4 weeks, the parasite invade the colonic mucosa, producing 
characteristic ulcerative lesions and a profuse bloody diarrhea (amoebic dysentery). 
Amoebic invasion through the mucosa and into the submucosa is the hallmark of amoebic 
colitis. Contact of the trophozoites via the Gal/GalNAc lectin triggers a signaling cascade  
initiating the death of the host cell through different mechanisms such as phagocytosis, 
cytotoxicity and caspase activation instigating the invasive (intestinal and/or extra-
intestinal) stages of the disease. Other molecules involved in the disease process include: a 
serine-rich E. histolytica protein (SREHP), amoebapores, and cysteine proteases (Boettner at 
al., 2002; Mortimer and Chadee, 2010).  Activation of damaging inflammatory and non-
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inflammatory responses following contact of the trophozoites to the gut wall induces a 
massive neutrophil infiltration across the epithelium into the underlying tissues resulting in 
weakening of epithelial cells and the mucous layer and allowing trophozoites to invade the 
intestinal epithelium and disseminating to other bodily sites (Ackers and Mirelman, 2006). 
The ulcers formed may be generalized involving the whole length of the large intestine or 
they may be localized in the ileo-caecal or sigmoido-rectal regions. Ulcers are normally 
disconnected with sizes varying from pin-head size to more than 2.5 cm in diameter. They 
may be deep or superficial. Base of the deep ulcers is generally formed by the muscularis 
layer. Nonetheless, superficial ulcers do not extend beyond the muscularis layer. A large 
number of fatalities results from perforated colons with concomitant peritonitis. E. histolytica 
also causes amoebomas. These are pseudotumoural lesions, whose formation is associated 
with necrosis, inflammation and oedema of the mucosa and submucosa of the colon. These 
granulomatous masses may obstruct the bowel.  
 
 
Fig. 3. “Flask-shaped” ulcer of invasive intestinal amebiasis (hematoxylin-eosin, original 
magnification ×50). Source: Pritt B S , Clark C G Mayo Clin Proc. 2008;83:1154-1160: Mayo 
Clinic Proceedings 
While the serine rich E. histolytica protein (SREHP) have been shown to promote adhesion of 
the trophozoites to host cells, cysteine proteases (CP), are known for their virulence in other 
protozoa as well as in tumour metastasis. Five E. histolytica proteins (EhCP1, 2, 3, 5 and 112) 
have been identified. All are alleged to play a role in the destruction of host cells, phagocytosis, 
together with the recruitment of neutrophils and macrophages and the induction of intestinal 
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inflammation (Mortimer and Chadee, 2010). Moreover, EhCP5 has also been shown to perform 
a variety of functions such as evasion of the host complement and immune system by 
preventing the activation of the classical complement system via the inactivation of IgG and 
the degradation of IgA (Laughlin and Temesvari, 2005).  
Equally important in the pathogenesis and virulence of E. histolytica is the role of the 
phagosome-associated proteins. Many have been identified and their function in 
endocytosis and pathogenesis has been established. Examples include: EhRacA, EhRacG, 
EhPAK, actin and several Rab7-related GTPases (Laughlin and Temesvari, 2005). Cytokines 
such as IL-1ǃ, IL-1ǂ, IL-8 and TNF-ǂ are suspected of aggravating the disease process and 
driving the immunopathogenesis mechanism (Kammanadiminti et al., 2003). Although 
neutrophils are known to cause intestinal tissue damage they are nevertheless critical for 
controlling the infection. Nonetheless, host and/or parasite factors normally play a role in 
determining whether the parasite is cleared or the disease becomes established (Asgharpour 
et al., 2005). 
Although most intestinal invasions heal following an acute inflammatory response, E. 
histolytica evades destruction in a modest number of individuals and a chronic state is 
established. This chronic state is associated with the development of a non-protective 
adaptive immune response. Human data, in vitro and in vivo models support a paradigm 
that Th1 responses in the gut clear E. histolytica, while Th2 responses through the production 
of IL-4 are anti-protective, likely through suppressing IFN-Ǆ. It is not yet clear what signals 
drive an anti-protective Th2 immune response instead of an effective protective Th1 
response towards the infection. Evidence suggesting that genetics, the MHC restriction, 
nutrition and bacterial flora might play a role in directing the immune response towards E. 
histolytica infection exists. For example, the MHC class II allele DQBl*0601 was reported to 
be associated with resistance to E. histolytica (Mortimer and Chadee, 2010). Susceptibility to 
ALA has been found to be associated with HLA-DR3 and complotype SC01 in some 
Mexican populations; this association is not seen for amoebic colitis or asymptomatic 
colonization with E. histolytica (Stanley, 2003).      
5.3 Extraintestinal amoebiasis 
About 5% individuals with intestinal amoebiasis, 1-3 months after the disappearance of the 
dysenteric attack, develop extraintestinal amoebiasis. Once in the blood, the parasite uses 
many different strategies to avoid elimination by the host and reaches other sites in the body 
(such as the liver, lungs, brain, etc). The most common extraintestinal site affected by the 
parasite is the liver and an Amoebic liver abscess (ALA) is its most common manifestation, 
predominantly seen in adult males. This chronic stage of ALA is characterized by defective 
cell-mediated immunity and the suppression of T cells and their defective proliferative 
responses (Campbell et al., 1999). E. histolytica trophozoites reaching the liver create their 
unique abscesses, which are well circumscribed regions of cytolysed liver cells, liquefied 
cells, and cellular debris. The lesions are surrounded by connective tissue enclosing few 
inflammatory cells and trophozoites. Parenchymal cells adjacent to the lesion are often 
unaffected. However, lysis of neutrophils by E. histolytica trophozoites might release 
mediators that lead to the death of liver cells, and extend damage to hepatocytes not in 
direct contact with the parasite. Studies have shown that in ALA in mice, most hepatocytes 
die from apoptosis, but necrosis is also present. In ALA from humans, the small numbers of 
amoebas relative to the size of the abscess suggests that E. histolytica can kill hepatocytes 
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without direct contact (Stanley 2003). From the liver, E. histolytica trophozoites may enter 
into the general circulation and reach other organs (Figure 4).  
 
 
Fig. 4. Amoebic Liver abscess.  Gross specimen of liver tissue with an abscess (white) that 
formed due to infection of the organ with Entamoeba histolytica. Source: 
http://www.sciencephoto.com/media/250248/enlarge 
6. Role of genetic characteristics of the infecting strains in the pathogenesis 
of amoebiasis 
The outcome of an infection may depend on several factors among which the genetic 
characteristics of the specific pathogen have been identified as an important one. Few 
polymorphic genetic loci have been identified and targeted to aid in the study of the 
population structure of E. histolytica strains and their possible relationships with the 
parasite's virulence and disease outcome (Clark, 2006; Paul et al., 2007). Examples of these 
genetic markers include protein coding genes (serine – rich E. histolytica protein, [SREHP] 
and Chitinase) and non-coding DNA (Strain Specific Gene and tRNA gene linked short 
tandem repeats [STR]) of PCR-amplified genes (Haghighi et al., 2003; Samie et al., 2008). In a 
study in Bangladesh, the tRNA-linked STR genotyping system has provided evidence that 
the parasite genome does influence the outcome of infection. tRNA-linked STR genotyping 
was also behind the recent observation of differences between parasite genotypes in the 
intestine and the liver abscess of same patients (Ali et al., 2007). Few studies, albeit 
inconclusive, using the polymorphic SREHP marker have indicated that certain SREHP 
profiles might be responsible for the presentation of intestinal amoebic symptoms (Ayeh-
kumi et al., 2001; Samie et al., 2008). Yet, all studies with SREHP marker did support 
previous findings of extensive genetic diversity among E. histolytica isolates from the same 
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geographic origin (Ayeh-kumi et al., 2001; Simonishvili et al., 2005; Samie et al., 2008; 
Tanyuksel et al., 2008). Thus, it seems that the parasite genotype does play a role in the 
outcome of infection in humans thus linking parasite diversity and virulence. Other 
approaches, such as SNP identification coupled with microarray-based analysis of gene 
expression or proteomic comparisons among parasites will be needed to identify the actual 
genes responsible for these results and to help us understand the mechanism of parasite 
virulence and pathogenesis (Ali et al., 2008).  
7. Conclusions  
Up to date, there are still large gaps in our knowledge of species prevalence rates in 
different regions of the world particularly in the African continent where very few studies 
are being conducted using molecular methods. In order to address this limitation, there is 
need to implement species-specific diagnosis of E. histolytica, E. dispar and E. moshkovskii, 
particularly in countries where these organisms are endemic.  Based on the limited 
information available to date it appears that molecular and genomic studies are still needed 
combined to molecular epidemiology studies in order to advance our understanding of 
amoebiasis. The currently available genome sequence is very useful in better understanding 
the biology of the parasite, however, E. histolytica strains from Africa still need to have the 
genome sequenced. Comparative genomics will probably allow the understanding of the 
pathogenicity of some strains of E. histolytica compared to non-pathogenic strains as well as 
better understanding of E. dispar in relation to E. histolytica.  Further collaborations between 
scientists from developed countries and those from developing countries is essential in 
answering questions on the epidemiology, pathogenesis and biochemistry of E. histolytica 
which is the causing agent of amoebiasis. 
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